Literature DB >> 14635795

Progesterone receptors in mammary gland development and tumorigenesis.

Orla M Conneely1, Biserka M Jericevic, John P Lydon.   

Abstract

The steroid hormone, progesterone (P), is a central coordinator of all aspects of female reproductive activity and plays a key role in pregnancy-associated mammary gland morphogenesis and mammary tumorigenesis. The effects of P on the mammary gland are mediated by two structurally and functionally distinct nuclear receptors PR-A and PR-B that arise from a single gene. Null mutation of both receptors in PR knockout (PRKO) mice has demonstrated a critical role for PRs in mediating pregnancy-associated mammary ductal branching and lobuloalveolar differentiation and in initiation of mammary tumors in response to carcinogen. Analysis of the molecular genetic pathways disrupted in PRKO mice has recently yielded important insights into the molecular mechanisms of regulation of mammary gland morphogenesis by PRs. In addition to its essential role in regulating proliferative and differentiative responses of the adult mammary gland during pregnancy, P plays a critical role in the protection against mammary tumorigenesis afforded by early parity. Thus, the effects of P on postnatal developmental plasticity of the mammary gland differ between young and adult glands. This review will summarize recent advances in our understanding of 1) the molecular mechanisms by which PRs mediate pregnancy-associated mammary gland morphogenesis, 2) the role of PRs in mediating tumorigenic responses of the adult mammary gland to carcinogen, and 3) the role of P in long-term protection of the juvenile mammary gland against tumorigenesis. In addition, we will summarize recent insights into the isoform selective contributions to some of these activities of PRs obtained from comparative analysis of P-dependent mammary gland development in PR isoform specific knockout mice lacking either the PR-A (PRAKO) or PR-B (PRBKO).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635795     DOI: 10.1023/a:1025952924864

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  68 in total

Review 1.  Breast cancer (1)

Authors:  J R Harris; M E Lippman; U Veronesi; W Willett
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

2.  A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development.

Authors:  Preeti M Ismail; Jie Li; Francesco J DeMayo; Bert W O'Malley; John P Lydon
Journal:  Mol Endocrinol       Date:  2002-11

Review 3.  A mutator phenotype in cancer.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

4.  IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.

Authors:  Cathrin Brisken; Ayyakkannu Ayyannan; Cuc Nguyen; Anna Heineman; Ferenc Reinhardt; Jian Tan; S K Dey; G Paolo Dotto; Robert A Weinberg; Tian Jan
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

Review 5.  Validity of mouse mammary tumour models for human breast cancer: comparative pathology.

Authors:  R D Cardiff
Journal:  Microsc Res Tech       Date:  2001-01-15       Impact factor: 2.769

6.  Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation.

Authors:  S Y Tsai; J Carlstedt-Duke; N L Weigel; K Dahlman; J A Gustafsson; M J Tsai; B W O'Malley
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

7.  Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.

Authors:  R L Arnett-Mansfield; A deFazio; G V Wain; R C Jaworski; K Byth; P A Mote; C L Clarke
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

8.  The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.

Authors:  P H Giangrande; E A Kimbrel; D P Edwards; D P McDonnell
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

9.  A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform.

Authors:  C A Sartorius; M Y Melville; A R Hovland; L Tung; G S Takimoto; K B Horwitz
Journal:  Mol Endocrinol       Date:  1994-10

Review 10.  Benefits and risks of hormone replacement therapy (HRT).

Authors:  M Breckwoldt; C Keck; U Karck
Journal:  J Steroid Biochem Mol Biol       Date:  1995-06       Impact factor: 4.292

View more
  41 in total

1.  Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.

Authors:  Victoria Wargon; Marina Riggio; Sebastián Giulianelli; Gonzalo R Sequeira; Paola Rojas; María May; María L Polo; María A Gorostiaga; Britta Jacobsen; Alfredo Molinolo; Virginia Novaro; Claudia Lanari
Journal:  Int J Cancer       Date:  2014-11-12       Impact factor: 7.396

2.  The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.

Authors:  Andrea R Daniel; Angela L Gaviglio; Lauren M Czaplicki; Christopher J Hillard; Daniel Housa; Carol A Lange
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 3.  The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk.

Authors:  Valerie A Flores; Hugh S Taylor
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06-23       Impact factor: 4.741

Review 4.  Hormonal and local control of mammary branching morphogenesis.

Authors:  Mark D Sternlicht; Hosein Kouros-Mehr; Pengfei Lu; Zena Werb
Journal:  Differentiation       Date:  2006-09       Impact factor: 3.880

5.  Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.

Authors:  Andrea R Daniel; Ming Qiu; Emily J Faivre; Julie Hanson Ostrander; Andrew Skildum; Carol A Lange
Journal:  Steroids       Date:  2006-12-14       Impact factor: 2.668

6.  Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation.

Authors:  Pingping Jiang; Qiuping Hu; Mitsuhiro Ito; Sara Meyer; Susan Waltz; Sohaib Khan; Robert G Roeder; Xiaoting Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

7.  Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Authors:  Ulla Simanainen; Yan Ru Gao; Kirsty A Walters; Geoff Watson; Reena Desai; Mark Jimenez; David J Handelsman
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

8.  The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Authors:  Yongxian Ma; Pragati Katiyar; Laundette P Jones; Saijun Fan; Yiyu Zhang; Priscilla A Furth; Eliot M Rosen
Journal:  Mol Endocrinol       Date:  2005-08-18

9.  Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.

Authors:  Chad J Creighton; Xiaoyong Fu; Bryan T Hennessy; Angelo J Casa; Yiqun Zhang; Ana Maria Gonzalez-Angulo; Ana Lluch; Joe W Gray; Powell H Brown; Susan G Hilsenbeck; C Kent Osborne; Gordon B Mills; Adrian V Lee; Rachel Schiff
Journal:  Breast Cancer Res       Date:  2010-06-22       Impact factor: 6.466

Review 10.  Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.

Authors:  James D Shull; Kirsten L Dennison; Aaron C Chack; Amy Trentham-Dietz
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.